Our results shed a mechanistic insight into the regulation of the AR gene in breast cancer cells, as absence of the PR is likely to abrogate the progesterone-mediated repression of the AR gene, while maintaining the positive regulation previously described for the ER in human endometrium [61] and mouse Fallopian tubes [62]. This evidence concerns the gene AR and breast cancer.